Predict your next investment

HEALTHCARE | Medical Devices & Equipment
apprivamed.com

See what CB Insights has to offer

Founded Year

1998

Stage

Acquired | Acquired

Total Raised

$18.4M

Valuation

$0000 

About Appriva Medical

Appriva Medical was a Healthcare/Medical Devices & Equipment company based in Sunnyvale, California. Appriva Medical was acquired in 2002.

Appriva Medical Headquarter Location

777 North Pastoria Avenue

Sunnyvale, California, 94085,

United States

408-617-0644

Latest Appriva Medical News

Covidien's Ev3 logs a pair of legal wins over Appriva, whistleblower

Oct 8, 2014

October 8, 2014 by Brad Perriello Covidien's Ev3 subsidiary logs a pair of legal wins, with the Delaware Supreme Court reversing a $250 million loss to Appriva and a Massachusetts federal judge tossing a whistleblower's lawsuit. Covidien  (NYSE: COV ) subsidiary Ev3 logged a pair of legal wins in recent weeks when the Delaware Supreme Court overturned a $250 million loss to Ev3 acquisition Appriva Medical and a federal judge in Massachusetts tossed a whistleblower's lawsuit. The Delaware Superior Court ruled in 2013 that ev3 broke its contract with Appriva Medical when it denied the $175 million milestone for Appriva's Plaato device, which it acquired in August 2002 for a $50 million cash payment plus milestones. Sign up to get our free newsletters delivered straight to your inbox Covidien in March asked the First State's Supremes to grant a new trial over the $175 million in milestones Appriva Medical alleges are owed from a 2002 acquisition. The high court reversed the superior court's ruling Sept. 30, finding that the lower court erred in erred in allowing the jury to interpret a portion of the ev3/Appriva deal and in interpreting the merger agreement to be subject to a previous, non-binding letter of intent. 1

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.